Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids

Neuroscience

Volumn 89, Issue 2, 1999, Pages 525-534

  Hua, X Y ^a   Chen, P ^a   Marsala, M ^a   Yaksh, T L ^a  

^a University of California   (United States)

Author keywords

Glutamate; Neurokinin 1 receptor; Prostaglandin; Spinal cord; Substance P; Thermal nociception

Indexed keywords

2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; GLUTAMIC ACID; NEUROKININ 1 RECEPTOR; NOLPITANTIUM; PROSTAGLANDIN E2; SUBSTANCE P;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DATA ANALYSIS; HYPERALGESIA; MALE; MICRODIALYSIS; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; RAT; SPINAL CORD;

AMINO ACIDS; ANALGESICS; ANIMALS; DINOPROSTONE; HEAT; HYPERALGESIA; INDOLES; INJECTIONS, SPINAL; MALE; PIPERIDINES; QUINUCLIDINES; RATS; RATS, INBRED STRAINS; RECEPTORS, NEUROKININ-1; SPINAL CORD; SUBSTANCE P;

EID: 0033103611     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00488-6     Document Type: Article

References (80)

1. 1. Andreeva L. and Rang H. P. (1993) Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vivo. Br. J. Pharmac. 108, 185-190.
2. 2. Barber R. P., Vaughn J. E., Slemmon J. R., Salvaterra P. M., Roberts E. and Leeman S. E. (1979) The origin, distribution and synaptic relationship of substance P axons in rat spinal cord. J. comp. Neurol. 184, 331-352.
3. 3. Basbaum A. (1991) Peripheral mechanisms of sensitization and hyperalgesia. In Anesthesiology and Pain Management (eds Stanley T., Ashburn M. and Fine P.), pp. 31-37. Kluwer, Academic Publishers, Dordrecht, Boston, London.
4. 4. Beiche F., Scheuerer S., Brune K., Geisslinger G. and Goppelt-Struebe M. (1996) Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. Fedn Eur. biochem. Socs Lett. 390, 165-169.
5. 5. Breder C. D., Dewitt D. and Kraig R. P. (1995) Characterization of inducible cyclooxygenase in rat brain. J. comp. Neurol. 355, 296-315.
6. 6. Breder C. D., Smith W. L., Raz A., Masferrer J., Seibert K., Needleman P. and Saper C. B. (1992) Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. J. comp. Neurol. 322, 409-438.
7. 7. Chapman V. and Dickenson A. H. (1993) The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord. Neurosci. Lett. 157, 149-152.
8. 8. Chen L. and Huang L. Y. (1991) Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 7, 319-326.
9. 2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 356, 521-523.
10. 2 is noradrenergic terminal-dependent. Neurosci. Lett. 115, 253-258.
11. 11. De Biasi S. and Rustioni A. (1988) Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc. natn. Acad Sci. U.S.A. 85, 7820-7824.
12. 12. Dickenson A. H. (1990) A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmac. 11, 307-309.
13. 13. Dirig D. M., Hua X.-Y. and Yaksh T. L. (1997) Temperature dependency of basal and evoked release of amino acids and calcitonin gene-related peptide from rat dorsal spinal cord. J. Neurosci. 17, 4406-4414.
14. 14. Dirig D. M. and Yaksh T. L. (1996) Thermal hyperalgesia in rat evoked by intrathecal substance P at multiple stimulus intensities reflects an increase in the gain of nociceptive processing. Neurosci. Lett. 220, 93-96.
15. 15. Dougherty P. M., Palecek J., Paleckova V. and Willis W. D. (1994) Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin. J. Neurophysiol. 72, 1464-1475.
16. 16. Gerber G. and Randic M. (1989) Excitatory amino acid-mediated component of synaptically evoked input from dorsal roots to deep dorsal horn neurons in spinal cord slice. Neurosci. Lett. 106, 211-219.
17. 17. Hargreaves K., Dubner R., Brown F., Flores C. and Joris J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-88.
18. 18. Henry J. L., Krnjevic K. and Morris M. E. (1975) Substance P and spinal neurons. Can. J. Physiol. Pharmac. 53, 423-434.
19. 19. Hershey A. D. and Krause J. E. (1990) Molecular characterization of a functional cDNA coding the rat substance P receptor. Science 247, 958-962.
20. 20. Hingtgen C. M., Waite K. J. and Vasko M. R. (1995) Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade. J. Neurosci. 15, 5411-5419.
21. 21. Hokfelt T., Kellerth J. O., Nilsson G. and Pernow B. (1975) Substance P localization in the central nervous system and in some primary sensory neurons. Science 190, 889-890.
22. 22. Holzer P. (1991) Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmac. Rev. 43, 143-201.
23. 23. Hornfeldt C. S., Smullin D. H., Schamber C. D., Sun X. and Larson A. A. (1992) Antinociceptive effects of intrathecal taurine and calcium in the mouse. Life Sci. 50, 1925-1934.
24. 2 release. NeuroReport 8, 2325-2329.
25. 25. Hughes P., Beilharz E., Gluckman P. and Dragunow M. (1993) Brain-derived neurotrophic factor is induced as an immediate early gene following N-methyl-D-aspartate receptor activation. Neuroscience 57, 319-328.
26. 26. Huskaar S., Berge O.-G. and Hole K. (1986) Dissociation between antinociceptive and anti-inflammatory effects of acetylsalicylic acid and indomethacin in the formalin test. Pain 25, 125-132.
27. 27. Hylden J. L. K. and Wilcox G. L. (1983) Pharmacological characterization of substance P induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level. J. Pharmac. exp. Ther. 226, 398-404.
28. 28. Jung M., Calassi R., Maruani J., Barnouin C., Souilhac J., Poncelet M., Gueudet C., Emonds-Alt X., Soubrie P., Breliere J. C. and Le Fur G. (1994) Neuropharmacological characterization of SR 140333, a non peptide anatagonist of NK1 receptors. Neuropharmacology 33, 167-179.
29. 29. Kangrga I. and Randic M. (1990) Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from the rat spinal dorsal horn slice. J. Neurosci. 10, 2026-2038.
30. 30. Kantner R., Kirby M. L. and Goldstein B. D. (1985) Increase in substance P in the dorsal horn during a chemogenic nociceptive stimulus. Brain Res. 338, 196-199.
31. 31. Kuraishi Y., Hirota N., Sato Y., Hanashima N., Takagi H. and Satoh M. (1989) Stimulus specificity of peripherally evoked substance P release from the rabbit dorsal horn in situ. Neuroscience 30, 241-250.
32. 32. Larson A. A. and Sun X. (1992) Amino terminus of substance P potentiates kainic acid-induced activity in the mouse spinal cord. J. Neurosci. 12, 4905-4910.
33. 33. Lehmann A., Hagberg H. and Hamberger A. (1984) A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation? Neurosci. Lett. 52, 341-346.
34. 34. Lembeck F. (1953) Zur Frage der zentralen ubertragung afferenter impulse III. Metteilung. Das Vollkommen und die Bedeutung der substanz P in den dorsalen Wurzeln des ruckenmarks. Naunyn-Schmiedebergs Arch. Pharmac. 219, 197-213.
35. 35. Levine J. D., Fields H. L. and Basbaum A. I. (1993) Peptides and the primary afferent nociceptor. J. Neurosci. 13, 2273-2286.
36. 36. Maehara T., Suzuki H., Yoshioka K. and Otsuka M. (1995) Characterization of substance P-evoked release of amino acids from neonatal rat spinal cord. Neuroscience 68, 577-584.
37. 37. Malmberg A. B. and Yaksh T. L. (1992) Antinociceptive action of spinal non-steroidal and anti-inflammatory agents on the formalin test in the rat. J. Pharmac. exp. Ther. 263, 136-146.
38. 38. Malmberg A. B. and Yaksh T. L. (1992) Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibitor. Science 257, 1276-1279.
39. 39. Malmberg A. B. and Yaksh T. L. (1994) Antinociception produced by spinal delivery of the S and R enantiomers of flurbiprofen in the formalin test [published erratum appears in Eur. J. Pharmac. (1994) 260, (2-3), 283]. Eur. J. Pharmac. 256, 205-209.
40. 2 release in spinal cord slices: relative effect of cyclooxygenase inhibitors. Eur. J. Pharmac. 271, 293-299.
41. 2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J. Neurosci. 15, 2768-2776.
42. 42. Marsala M., Malmberg A. and Yaksh T. L. (1995) The spinal loop dialysis catherter: characterisation of use in the unanesthetized rats. J. Neurosci. Meth. 62, 43-53.
43. 43. Martin H. A., Basbaum A. I., Kwiat G. C., Goetzl E. J. and Levine J. D. (1987) Leukotriene and prostaglandin sensitization of cutaneous high-threshold C-and A-δ mechanonociceptors in the hairy skin of rat hindlimbs. Neuroscience 22, 651-659.
44. 44. Matsumura H., Sakurada T., Hara A., Sakurada S. and Kisara K. (1985) Characterization of the hyperalgesic effect induced by intrathecal injection of substance P. Neuropharmacology 24, 421-426.
45. 45. Mayer M. L. and Westbrook G. L. (1987) The physiology of excitatory amino acids in vertebrate central nervous system. Prog. Neurobiol. 28, 197-276.
46. 46. McCarson K. E. and Goldstein B. D. (1991) Release of substance P into the superficial dorsal horn following nociceptive activation of the hind-paw of the rat. Brain Res. 568, 109-116.
47. 47. Meller S. T. and Gebhart G. F. (1993) Nitric oxide (NO) and nociceptive processing in the spinal cord [see comments]. Pain 52, 127-136.
48. 48. Neugebauer V., Weiretter F. and Schaible H.-G. (1995) Involvement of substance P and neurokinin-1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J. Neurophysiol. 73, 1574-1583.
49. 49. Neumann S., Doubell T. P., Leslie T. and Woolf C. J. (1996) Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 384, 360-364.
50. 2 increases calcium conductance and stimulates release of substance P in avian sensory neurons. J. Neurosci. 12, 1917-1927.
51. 51. Otsuka M., Konishi S., Yanagisawa M., Tsnoo A. and Akagi H. (1982) Role of substance P as a sensory transmitter in spinal cord and sympathetic ganglia. In Substance P in the Nervous System. Ciba Foundation Symposium (eds Porter R. and O'Connor M.), pp. 13-34, Vol. 91. Pitman, London.
52. 52. Pernow B. (1983) Substance P. Pharmac. Rev. 35, 85-141.
53. 53. Piercey M. F., Dobry P. K., Schroeder L. A. and Einspahr F. J. (1981) Behavioral evidence that substance P may be a spinal cord sensory neurotransmitter. Brain Res. 210, 407-412.
54. 54. Puig S. and Sorkin L. S. (1995) Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 64, 345-355.
55. 55. Randic M. and Miletic V. (1977) Effects of substance P in cat dorsal horn neurones activated by noxious stimuli. Brain Res. 128, 164-169.
56. 56. Ranwell P. W., Shaw J. E. and Jessup R. (1966) Spontaneous and evoked release of prostaglandins from frog spinal cord. Am. J. Physiol. 211, 998-1004.
57. 57. Rueff A. and Dray A. (1993) Sensitization of peripheral afferent fibers in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins. Neuroscience 54, 527-535.
58. 58. Rusin K. I., Ryu P. D. and Randic M. (1992) Modulation of excitatory amino acid responses in rat dorsal horn neurons by tachykinins. J. Neurophysiol. 68, 265-286.
59. 59. Salt T. E. and Hill R. G. (1983) Neurotransmitter candidates of somatosensory primary afferent fibers. Neuroscience 10, 1083-1103.
60. 60. Serrano J. S., Serrano M. I., Guerrero M. R., Ruiz R. and Polo J. (1990) Antinociceptive effect of taurine and its inhibition by naxolone. Gen. Pharmac. 21, 333-336.
61. 61. Skilling S. R., Smulling D. H., Beitz A. J. and Larson A. A. (1988) Extracellular amino acid concentrations in dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation. J. Neurochem. 51, 127-132.
62. 62. Sluka K. A. and Westlund K. N. (1993) Spinal cord amino acid release and content in an arthritis model: the effects of pretreatment with non-NMDA, NMDA, and NK1 receptor antagonist. Brain Res. 627, 89-103.
63. 63. Smullin D. H., Skilling S. R. and Larson A. A. (1990) Interaction between substance P, calcitonin-gene-related peptide, taurine and excitatory amino acids in the spinal cord. Pain 42, 93-101.
64. 64. Sorkin L. S. and Moore J. H. (1996) Evoked release of amino acids and prostanoids in spinal cords of anesthetized rats: changes during peripheral inflammation and hyperalgesia. Am. J. Therapeut. 3, 268-275.
65. 65. Taiwo Y. and Levine J. D. (1988) Prostaglandins inhibit endogenous control mechanism by blocking transmission at spinal noradrenergic synapses. J. Neurosci. 8, 1346-1349.
66. 66. Thompson S. W. N., Dray A. and Urban L. (1994) Injury-induced plasticity of spinal reflex activity: NK1 neurokinin receptor activation and enhanced A- and C-fiber-mediated response in the rat spinal cord. J. Neurosci. 14, 3672-3687.
67. 2α to conscious mice. Brain Res. 510, 26-32.
68. 68. Urban L. and Randic M. (1984) Slow excitatory transmission in rat dorsal horn: possible mediation by peptides. Brain Res. 290, 336-341.
69. 69. Urban L., Thompson S. W. N. and Dray A. (1994) Modulation of spinal excitability: cooperation between neurokinin and excitatory amino acid transmission. Trends Neurosci. 17, 432-438.
70. 2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture. J. Neurosci. 14, 4987-4997.
71. 71. Wanaka A., Shiotani Y., Kiyama H., Matsuama T., Kamada T., Shiosaka S. and Tohyama M. (1987) Glutamate-like immunoreactive structures in primary sensory neurons in the rat detected by a specific antiserum against glutamate. Expl Brain Res. 65, 691-694.
72. 72. Watkins J. C. and Evans R. H. (1981) Excitatory amino acid transmitters. A. Rev. Pharmac. Toxicol. 21, 165-204.
73. 73. Yaksh T. L. (1982) Central and peripheral mechanisms for the analgesic action of acetylsalicylic acid. In Acetylsalicylic Acid: New Uses for an Old Drug (eds Barett H. J. M., Hirsh J. and Mustard J. F.), pp. 137-151. Raven, New York.
74. 74. Yaksh T. L., Jessell T. M., Gamse R., Mudge A. W. and Leeman S. E. (1980) Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature 286, 455-457.
75. 75. Yamamoto D. (1988) Activation of protein kinase C promotes glutamate-mediated transmission at the neuromuscular junction of the mealworm. J. Physiol., Lond. 400, 691-700.
76. 76. Yamamoto T. and Yaksh T. L. (1991) Stereospecific effects of a nonpeptide NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci. 49, 1955-1963.
77. 77. Yamamoto T. and Yaksh T. L. (1992) Comparison of antinociceptive effects of pre- and post-treatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology 77, 757-763.
78. 2 release after carrageenan/kaolin-induced knee joint inflammation: a chronic microdialysis study. Pain 67, 345-354.
79. 79. Yasphal K., Wright D. M. and Henry J. L. (1976) Substance P reduces tail-flick latency: implication for chronic pain. Pain 14, 155-167.
80. 80. Yokota Y., Sasai Y., Tanaka K., Fujiwara T., Tsuchida K., Shigemoto R., Kakizuka A., Ohkubo H. and Nakanishi S. (1989) Molecular characterization of a functional cDNA for rat substance P receptor. J. biol Chem. 264, 17,649-17,652.